AI devices with FDA product code QXO — Cardiovascular Machine Learning-Based Notification Software

Product code QXO (“Cardiovascular Machine Learning-Based Notification Software” in openFDA) covers 2 devices on the FDA AI-enabled list, from 2 companies. Most are reviewed by the Cardiovascular panel (2). The most recent decision was EchoNext on June 8, 2026.